RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome

Clinical trial NCT00621855 · COMPLETED

Trial details

NCT number: NCT00621855
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Disease

Start date: 2008-03-01
Primary completion: 2009-10-01
Enrollment: 1878

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.